Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
LXEO Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LXEO Stock 12 Month Forecast
Average Price Target
$18.80
▲(225.82% Upside)
| Highest Price Target$25.00 | Average Price Target$18.80 | Lowest Price Target$10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Oppenheimer
$20
Buy
246.62%
Upside
Reiterated
03/31/26
Cantor Fitzgerald
$19
Buy
229.29%
Upside
Reiterated
03/30/26
RBC Capital
$20
Buy
246.62%
Upside
Reiterated
03/30/26
H.C. Wainwright
$13→$10
Buy
73.31%
Upside
Reiterated
01/13/26
Raymond James
$10.54→$25
Buy
333.28%
Upside
Reiterated
01/13/26
Chardan Capital
$17
Buy
194.63%
Upside
Reiterated
11/05/25
Leerink Partners
$20→$18
Buy
211.96%
Upside
Reiterated
10/21/25
Guggenheim
$30
Buy
419.93%
Upside
Initiated
10/15/25
J.P. Morgan
―
Buy
―
Reiterated
10/07/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Oppenheimer
$20
Buy
246.62%
Upside
Reiterated
03/31/26
Cantor Fitzgerald
$19
Buy
229.29%
Upside
Reiterated
03/30/26
RBC Capital
$20
Buy
246.62%
Upside
Reiterated
03/30/26
H.C. Wainwright
$13→$10
Buy
73.31%
Upside
Reiterated
01/13/26
Raymond James
$10.54→$25
Buy
333.28%
Upside
Reiterated
01/13/26
Chardan Capital
$17
Buy
194.63%
Upside
Reiterated
11/05/25
Leerink Partners
$20→$18
Buy
211.96%
Upside
Reiterated
10/21/25
Guggenheim
$30
Buy
419.93%
Upside
Initiated
10/15/25
J.P. Morgan
―
Buy
―
Reiterated
10/07/25
Best Analysts Covering Lexeo Therapeutics, Inc.
3 Months
xxx
Success Rate
8/14 ratings generated profit
Average Return
+18.63%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +18.63% per trade.
1 Year
Success Rate
6/12 ratings generated profit
Average Return
+13.53%
reiterated a buy rating 3 months ago
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +13.53% per trade.
2 Years
xxx
Success Rate
4/11 ratings generated profit
Average Return
+5.44%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 36.36% of your transactions generating a profit, with an average return of +5.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LXEO Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
11
7
5
6
4
Buy
4
4
2
2
0
Hold
1
13
13
16
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
24
20
24
10
Each month's total comprises the sum of three months' worth of ratings.
LXEO Financial Forecast
LXEO Stock Forecast FAQ
What is LXEO’s average 12-month price target, according to analysts?
Based on analyst ratings, Lexeo Therapeutics, Inc.’s 12-month average price target is 18.80.
What is LXEO’s upside potential, based on the analysts’ average price target?
Lexeo Therapeutics, Inc. has 225.82% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LXEO a Buy, Sell or Hold?
Lexeo Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lexeo Therapeutics, Inc.’s price target?
The average price target for Lexeo Therapeutics, Inc. is 18.80. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $10.00. The average price target represents 225.82% Increase from the current price of $5.77.
The highest analyst price target is $25.00 ,the lowest forecast is $10.00. The average price target represents 225.82% Increase from the current price of $5.77.
What do analysts say about Lexeo Therapeutics, Inc.?
Lexeo Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of LXEO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.